NANCY BARNHOUSE: Open Payments
NPI 1609060169 · TITUSVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$609 in 31 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $609
Food & beverage: $609
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $216 |
| AstraZeneca Pharmaceuticals LP | 6 | $142 |
| Esperion Therapeutics, Inc. | 3 | $64 |
| Amgen Inc. | 2 | $41 |
| ABBVIE INC. | 1 | $33 |
| Exact Sciences Corporation | 1 | $30 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Cipher Pharmaceuticals US LLC | 1 | $19 |
| Indivior Inc. | 1 | $17 |
Products named: CAPLYTA, FARXIGA, NEXLETOL, BREZTRI, KRYSTEXXA, MAVYRET, Cologuard Collection Kit, FANAPT.
Industry payments across FL — which companies pay providers there.
